These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39033904)

  • 1. Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.
    Lu XY; Li MQ; Li YT; Yao JY; Zhang LX; Zeng ZH; Yu-Liu ; Chen ZR; Li CQ; Zhou XF; Li F
    Neuropharmacology; 2024 Nov; 258():110089. PubMed ID: 39033904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
    Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
    Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis.
    Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
    Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
    Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
    Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
    Matsuo K; Yabuki Y; Fukunaga K
    Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway.
    Elesawy RO; El-Deeb OS; Eltokhy AK; Arakeep HM; Ali DA; Elkholy SS; Kabel AM
    Biomed Pharmacother; 2022 Jun; 150():112960. PubMed ID: 35447549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders.
    Gąssowska-Dobrowolska M; Cieślik M; Czapski GA; Jęśko H; Frontczak-Baniewicz M; Gewartowska M; Dominiak A; Polowy R; Filipkowski RK; Babiec L; Adamczyk A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
    Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
    Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
    Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
    Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
    Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism.
    Liu C; Guo Z; Pang J; Zhang Y; Yang Z; Cao J; Zhang T
    Behav Brain Res; 2024 Jul; 469():115052. PubMed ID: 38782096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
    Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
    Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Eur J Pharmacol; 2021 Jan; 890():173663. PubMed ID: 33127361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Kumar H; Sharma BM; Sharma B
    Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.
    Gholipour P; Ebrahimi Z; Mohammadkhani R; Ghahremani R; Salehi I; Sarihi A; Komaki A; Karimi SA
    Sci Rep; 2024 Jun; 14(1):13168. PubMed ID: 38849397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.